Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medreleaf Corp Ord T.LEAF

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

1933 Industries Bruce Campbell's top picks 100 million in revenue next year they sell some concentrates up to  $120 a G!  rate and reply

Article Mentions MedReleaf

Click Here For Article  rate and reply

Ayurcann Holdings expands product offerings across Canada

“We are thrilled with the growth of Ayurcann and its products within the Canadian marketplace. With the ability to produce products that are embraced by cannabis consumers, offering value and innovation, we are optimistic about our future growth and the potential of becoming an industry leader. We have been successfully selling throughout various Provinces within Canada, including Ontario, British Columbia, Alberta, New Brunswick, Manitoba, and Saskatchewan" - CEO Igal Sudman more

next Canopy Growth Corporation

"TORONTO, August 21, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. (“ more

Tgif will be a MONSTER!

Established licensed cultivator and producer in Nevada’s Emerging Medical and Recreational Cannabis Markets more

LEAF and ACB Confirm SA with OCS  rate and reply

OCS Secures Supply Agreement with LP's to ensure Readiness


RE:RE:When do our shares get converted to Aurora?

When shares get converted is in the hands of the transfer agent. This can take upward of 10 banking days (two weeks). Assuming your shares are in an investment account, you should see 3.575 times more

RE:When do our shares get converted to Aurora?

I have been wondering the same thing. I was expecting them to convert today but so far nothing.   rate and reply

When do our shares get converted to Aurora?

Just wondering when the shares get converted. Mine are still under MedReleaf but it’s not like I can trade them or anything.  rate and reply

RE:Now that the merger is complete

RIP MedReleaf.... You're in good hands... You'll fly like an angel... Future is green  rate and reply

RE:Merged Entity Market Cap Shrunk by $600 million.

  rate and reply

Merged Entity Market Cap Shrunk by $600 million.


RE:Clearly manipulation

You are right there is manipulation and collusion. On May 11th LEAF closed at 24.90 and ACB closed at 8.07. The closing ratio (24.90/8.07) = 3.086. This closing ratio is 15% less than the deal more

LEAF shareholders were had! Filing Complaint!

At the time of the deal announcement (May 11), LEAF shareholders were lulled into believing ACBs offer of 3.575 ACB/LEAF represented a 34% premium. While 34% sounds sweet, it had nothing to do more

Clearly manipulation

When I first purchased leaf, I stood to gain approx $7 per share after the 1 share of lead was converted to 3.57 acb shares. Seems odd that the day it becomes final, I break exactly even after more

RE:RE:good think acb went down 25% this month you get more shares

+1 Yes, it's rather obvious that some people should NOT be "investing" their money here when they don't even understand how a straight forward deal like this simple one works. more

RE:good think acb went down 25% this month you get more shares

How can you have more share?...ratio 3.575 didn't change....  rate and reply

Management & Board Changes

Management and Board Changes Following today's closing of the Arrangement Agreement, Neil Closner has stepped down as CEO of MedReleaf and during the integration process, more

RE:RE:LEAF shareholders are being short changed on ACB share swap.

Ahh.. I don't think so... LEAF shares were doing just fine until ACB got into the act. From a statistical standpoint since the deal was announced, the stocks (both ACB and LEAF) have suffered. more

RE:RE:RE:share conversions

Are you serious??  You really don't know??  rate and reply